These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 15514379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U, Buettner PG, Eigentler TK, Garbe C.
    J Clin Oncol; 2004 Sep 15; 22(18):3660-7. PubMed ID: 15302905
    [Abstract] [Full Text] [Related]

  • 3. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG, Leiter U, Eigentler TK, Garbe C.
    Cancer; 2005 Feb 01; 103(3):616-24. PubMed ID: 15630700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
    Averbook BJ, Russo LJ, Mansour EG.
    Surgery; 1998 Oct 01; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
    Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ.
    Ann Surg Oncol; 2004 Apr 01; 11(4):426-33. PubMed ID: 15070604
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E, Mangone L, Lo Scocco G, Carli P.
    Melanoma Res; 2006 Oct 01; 16(5):429-33. PubMed ID: 17013092
    [Abstract] [Full Text] [Related]

  • 12. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
    Garbe C, Ellwanger U, Tronnier M, Brocker EB, Orfanos CE.
    Cancer; 2002 Apr 15; 94(8):2305-7. PubMed ID: 12001131
    [No Abstract] [Full Text] [Related]

  • 13. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
    Gimotty PA, Botbyl J, Soong SJ, Guerry D.
    J Clin Oncol; 2005 Nov 01; 23(31):8065-75. PubMed ID: 16258105
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG, Mihm MC, Bufalino R, Zurrida S, Collini P, Cascinelli N.
    Cancer; 1996 Apr 01; 77(7):1303-10. PubMed ID: 8608507
    [Abstract] [Full Text] [Related]

  • 15. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W.
    Am Surg; 2000 Jun 01; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [Abstract] [Full Text] [Related]

  • 16. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F, Kurul S, Camlica H, Topuz E.
    Jpn J Clin Oncol; 2006 Dec 01; 36(12):794-9. PubMed ID: 17060409
    [Abstract] [Full Text] [Related]

  • 17. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 01; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 18. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA, Sanders LL, Edwards LJ, Seigler HF, Tyler DS, Grichnik JM.
    Cancer; 2001 Mar 01; 91(5):983-91. PubMed ID: 11251950
    [Abstract] [Full Text] [Related]

  • 19. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma.
    Ramacciato G, Mercantini P, Cautero N, Corigliano N, Di Benedetto F, Quintini C, Ercolani G, Varotti G, Ziparo V, Pinna AD.
    Ann Surg Oncol; 2005 Apr 01; 12(4):289-97. PubMed ID: 15827681
    [Abstract] [Full Text] [Related]

  • 20. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
    Gutzmer R, Satzger I, Thoms KM, Völker B, Mitteldorf C, Kapp A, Bertsch HP, Kretschmer L.
    J Dtsch Dermatol Ges; 2008 Mar 01; 6(3):198-203. PubMed ID: 18093216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.